Additional well-designed studies with larger sample sizes and long-term follow-up periods, that encompass different ethnic groups, may be required to better elucidate the causal relationship between CD35 polymorphism and HCC risk and prognosis. Here, CR1 is linked to hepatocellular carcinoma.